Loading...

Roselle Abraham, MD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Phone415-514-0992
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    CLINICAL INTERESTS: Dr. Roselle Abraham is a cardiologist with expertise in the treatment of patients with hypertrophic cardiomyopathy.

    RESEARCH INTERESTS: Dr. Roselle Abraham is a physician scientist with a background in electrophysiology, imaging and stem cell research. She is using multi-modality imaging for risk stratification of atrial and ventricular arrhythmias. The overall goal of her research program is to use a combination of multi-modality clinical imaging and studies in model systems to tailor therapies for patients with hypertrophic cardiomyopathy.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Yalcin H, Valenta I, Zhao M, Tahari A, Lu DY, Higuchi T, Yalcin F, Kucukler N, Soleimanifard Y, Zhou Y, Pomper MG, Abraham TP, Tsui B, Lodge MA, Schindler TH, Abraham MR. Correction to: Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy. J Nucl Cardiol. 2019 Aug; 26(4):1254. PMID: 29423907.
      View in: PubMed
    2. Bhattacharya M, Lu DY, Kudchadkar SM, Greenland GV, Lingamaneni P, Corona-Villalobos CP, Guan Y, Marine JE, Olgin JE, Zimmerman S, Abraham TP, Shatkay H, Abraham MR. Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model). Am J Cardiol. 2019 05 15; 123(10):1681-1689. PMID: 30952382.
      View in: PubMed
    3. Vakrou S, Fukunaga R, Foster DB, Sorensen L, Liu Y, Guan Y, Woldemichael K, Pineda-Reyes R, Liu T, Tardiff JC, Leinwand LA, Tocchetti CG, Abraham TP, O'Rourke B, Aon MA, Abraham MR. Allele-specific differences in transcriptome, miRNome, and mitochondrial function in two hypertrophic cardiomyopathy mouse models. JCI Insight. 2018 03 22; 3(6). PMID: 29563334.
      View in: PubMed
    4. Lu DY, Pozios I, Haileselassie B, Ventoulis I, Liu H, Sorensen LL, Canepa M, Phillip S, Abraham MR, Abraham TP. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2018 02 25; 7(5). PMID: 29478967.
      View in: PubMed
    5. Pozios I, Pinheiro A, Corona-Villalobos C, Sorensen LL, Dardari Z, Liu HY, Cresswell K, Phillip S, Bluemke DA, Zimmerman SL, Abraham MR, Abraham TP. Rest and Stress Longitudinal Systolic Left Ventricular Mechanics in Hypertrophic Cardiomyopathy: Implications for Prognostication. J Am Soc Echocardiogr. 2018 05; 31(5):578-586. PMID: 29426649.
      View in: PubMed
    6. Lu DY, Yalçin H, Yalçin F, Zhao M, Sivalokanathan S, Valenta I, Tahari A, Pomper MG, Abraham TP, Schindler TH, Abraham MR. Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 05 01; 121(9):1081-1089. PMID: 29678336.
      View in: PubMed
    7. Yalcin H, Valenta I, Zhao M, Tahari A, Lu DY, Higuchi T, Yalcin F, Kucukler N, Soleimanifard Y, Zhou Y, Pomper MG, Abraham TP, Tsui B, Lodge MA, Schindler TH, Roselle Abraham M. Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy. J Nucl Cardiol. 2019 Aug; 26(4):1243-1253. PMID: 29359273.
      View in: PubMed
    8. Lu DY, Haileselassie B, Ventoulis I, Liu HY, Liang HY, Pozios I, Canepa M, Phillip S, Abraham MR, Abraham T. E/e' ratio and outcome prediction in hypertrophic cardiomyopathy: the influence of outflow tract obstruction. Eur Heart J Cardiovasc Imaging. 2018 01 01; 19(1):101-107. PMID: 28977350.
      View in: PubMed
    9. Lu DY, Hailesealassie B, Ventoulis I, Liu H, Liang HY, Nowbar A, Pozios I, Canepa M, Cresswell K, Luo HC, Abraham MR, Abraham TP. Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy. Int J Cardiol. 2017 Sep 15; 243:290-295. PMID: 28747034.
      View in: PubMed
    10. Li Z, Guo X, Sun G, Zheng L, Sun Y, Liu Y, Abraham MR. Plasma homocysteine levels associated with a corrected QT interval. BMC Cardiovasc Disord. 2017 07 11; 17(1):182. PMID: 28693429.
      View in: PubMed
    11. Chu LC, Corona-Villalobos CP, Halushka MK, Zhang Y, Pozzessere C, Kamel IR, Pozios I, Van Der Geest RJ, Gai N, Abraham RM, Abraham TP, Bluemke DA, Zimmerman SL. Structural and Functional Correlates of Myocardial T1 Mapping in 321 Patients With Hypertrophic Cardiomyopathy. J Comput Assist Tomogr. 2017 Jul/Aug; 41(4):653-660. PMID: 27997439.
      View in: PubMed
    12. Liu H, Pozios I, Haileselassie B, Nowbar A, Sorensen LL, Phillip S, Lu DY, Ventoulis I, Luo H, Abraham MR, Abraham TP. Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy. Am J Cardiol. 2017 Aug 15; 120(4):670-675. PMID: 28687124.
      View in: PubMed
    13. Corona-Villalobos CP, Saha S, Pozios I, Hurtado-de-Mendoza Paz D, Sorensen L, Gonzalez Cordoba J, Dolores-Cerna K, Kamel IR, Mormontoy Laurel W, Bluemke DA, Abraham TP, Zimmerman SL, Abraham MR. Exercise-QTc is associated with diffuse interstitial fibrosis reflected by lower approximated T1 relaxation time in hypertrophic cardiomyopathy patients. J Electrocardiol. 2017 Jul - Aug; 50(4):484-490. PMID: 28292523.
      View in: PubMed
    14. Hurtado-de-Mendoza D, Corona-Villalobos CP, Pozios I, Gonzales J, Soleimanifard Y, Sivalokanathan S, Montoya-Cerrillo D, Vakrou S, Kamel I, Mormontoy-Laurel W, Dolores-Cerna K, Suarez J, Perez-Melo S, Bluemke DA, Abraham TP, Zimmerman SL, Abraham MR. Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy. J Arrhythm. 2017 Jun; 33(3):201-207. PMID: 28607615.
      View in: PubMed
    15. Sorensen LL, Liang HY, Pinheiro A, Hilser A, Dimaano V, Olsen NT, Hansen TF, Sogaard P, Nowbar A, Pisanello C, Pozios I, Phillip S, Zhou X, Abraham R, Abraham TP. Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy. Am Heart J. 2017 02; 184:47-54. PMID: 27892886.
      View in: PubMed
    16. Yalçin H, Valenta I, Yalçin F, Corona-Villalobos C, Vasquez N, Ra J, Kucukler N, Tahari A, Pozios I, Zhou Y, Pomper M, Abraham TP, Schindler TH, Abraham MR. Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by 13N-Ammonia Perfusion PET in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2016 Dec 15; 118(12):1908-1915. PMID: 27771003.
      View in: PubMed
    17. Li Z, Guo X, Liu Y, Zhang N, Chang Y, Chen Y, Sun Y, Abraham MR. Metabolism rather than obesity is associated with ischemic stroke: a cross-sectional study in rural Northeastern China. Springerplus. 2016; 5(1):1419. PMID: 27625973.
      View in: PubMed
    18. Li Z, Guo X, Liu Y, Chang Y, Sun Y, Zhu G, Abraham MR. The Relation of Moderate Alcohol Consumption to Hyperuricemia in a Rural General Population. Int J Environ Res Public Health. 2016 07 20; 13(7). PMID: 27447659.
      View in: PubMed
    19. Lin X, Steinberg S, Kandasamy SK, Afzal J, Mbiyangandu B, Liao SE, Guan Y, Corona-Villalobos CP, Matkovich SJ, Epstein N, Tripodi D, Huo Z, Cutting G, Abraham TP, Fukunaga R, Abraham MR. Common miR-590 Variant rs6971711 Present Only in African Americans Reduces miR-590 Biogenesis. PLoS One. 2016; 11(5):e0156065. PMID: 27196440.
      View in: PubMed
    20. Corona-Villalobos CP, Sorensen LL, Pozios I, Chu L, Eng J, Abraham MR, Abraham TP, Kamel IR, Zimmerman SL. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography. Int J Cardiovasc Imaging. 2016 Jun; 32(6):945-54. PMID: 26896038.
      View in: PubMed
    21. Sørensen LL, Bedja D, Sysa-Shah P, Liu H, Maxwell A, Yi X, Pozios I, Olsen NT, Abraham TP, Abraham R, Gabrielson K. Echocardiographic Characterization of a Murine Model of Hypertrophic Obstructive Cardiomyopathy Induced by Cardiac-specific Overexpression of Epidermal Growth Factor Receptor 2. Comp Med. 2016; 66(4):268-77. PMID: 27538857.
      View in: PubMed
    22. Ardekani S, Jain S, Sanzi A, Corona-Villalobos CP, Abraham TP, Abraham MR, Zimmerman SL, Wu KC, Winslow RL, Miller MI, Younes L. Shape analysis of hypertrophic and hypertensive heart disease using MRI-based 3D surface models of left ventricular geometry. Med Image Anal. 2016 Apr; 29:12-23. PMID: 26766206.
      View in: PubMed
    23. Pozios I, Corona-Villalobos C, Sorensen LL, Bravo PE, Canepa M, Pisanello C, Pinheiro A, Dimaano VL, Luo H, Dardari Z, Zhou X, Kamel I, Zimmerman SL, Bluemke DA, Abraham MR, Abraham TP. Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy. Am J Cardiol. 2015 Sep 15; 116(6):938-44. PMID: 26239580.
      View in: PubMed
    24. Bravo PE, Luo HC, Pozios I, Zimmerman SL, Corona-Villalobos CP, Sorensen L, Kamel IR, Bluemke DA, Wahl RL, Abraham MR, Abraham TP. Late gadolinium enhancement confined to the right ventricular insertion points in hypertrophic cardiomyopathy: an intermediate stage phenotype? Eur Heart J Cardiovasc Imaging. 2016 Mar; 17(3):293-300. PMID: 26077330.
      View in: PubMed
    25. Bravo PE, Tahari A, Pozios I, Luo HC, Bengel FM, Wahl RL, Abraham MR, Abraham TP. Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms. J Nucl Cardiol. 2016 12; 23(6):1304-1314. PMID: 25989730.
      View in: PubMed
    26. Rahman QA, Tereshchenko LG, Kongkatong M, Abraham T, Abraham MR, Shatkay H. Utilizing ECG-Based Heartbeat Classification for Hypertrophic Cardiomyopathy Identification. IEEE Trans Nanobioscience. 2015 Jul; 14(5):505-12. PMID: 25915962.
      View in: PubMed
    27. Luo HC, Dimaano VL, Kembro JM, Hilser A, Hurtado-de-Mendoza D, Pozios I, Tomas MS, Yalcin H, Dolores-Cerna K, Mormontoy W, Aon MA, Cameron D, Bluemke DA, Stewart KJ, Russell SD, Cordova JG, Abraham TP, Abraham MR. Exercise heart rates in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2015 Apr 15; 115(8):1144-1150. PMID: 25746289.
      View in: PubMed
    28. Rahman QA, Tereshchenko LG, Kongkatong M, Abraham T, Abraham MR, Shatkay H. Identifying Hypertrophic Cardiomyopathy Patients by Classifying Individual Heartbeats from 12-lead ECG Signals. Proceedings (IEEE Int Conf Bioinformatics Biomed). 2014 Nov; 2014:224-229. PMID: 25737801.
      View in: PubMed
    29. Luo HC, Pozios I, Vakrou S, Sorensen L, Abraham RM, Abraham T. Age-related changes in familial hypertrophic cardiomyopathy phenotype in transgenic mice and humans. J Huazhong Univ Sci Technolog Med Sci. 2014 Oct; 34(5):634-639. PMID: 25318870.
      View in: PubMed
    30. Vakrou S, Abraham MR. Hypertrophic cardiomyopathy: a heart in need of an energy bar? Front Physiol. 2014; 5:309. PMID: 25191275.
      View in: PubMed
    31. Canepa M, Sorensen LL, Pozios I, Dimaano VL, Luo HC, Pinheiro AC, Strait JB, Brunelli C, Abraham MR, Ferrucci L, Abraham TP. Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy. Am J Cardiol. 2013 Oct 15; 112(8):1182-9. PMID: 24079444.
      View in: PubMed
    32. Lin X, Liang HY, Pinheiro A, Dimaano V, Sorensen L, Aon M, Tereshchenko LG, Chen Y, Xiang M, Abraham TP, Abraham MR. Electromechanical relationship in hypertrophic cardiomyopathy. J Cardiovasc Transl Res. 2013 Aug; 6(4):604-15. PMID: 23771430.
      View in: PubMed
    33. Abraham MR, Bottomley PA, Dimaano VL, Pinheiro A, Steinberg A, Traill TA, Abraham TP, Weiss RG. Creatine kinase adenosine triphosphate and phosphocreatine energy supply in a single kindred of patients with hypertrophic cardiomyopathy. Am J Cardiol. 2013 Sep 15; 112(6):861-6. PMID: 23751935.
      View in: PubMed
    34. Bravo PE, Zimmerman SL, Luo HC, Pozios I, Rajaram M, Pinheiro A, Steenbergen C, Kamel IR, Wahl RL, Bluemke DA, Bengel FM, Abraham MR, Abraham TP. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):210-7. PMID: 23418294.
      View in: PubMed
    35. Hueper K, Zapf A, Skrok J, Pinheiro A, Goldstein TA, Zheng J, Zimmerman SL, Kamel IR, Abraham R, Wacker F, Bluemke DA, Abraham T, Vogel-Claussen J. In hypertrophic cardiomyopathy reduction of relative resting myocardial blood flow is related to late enhancement, T2-signal and LV wall thickness. PLoS One. 2012; 7(7):e41974. PMID: 22860042.
      View in: PubMed
    36. Bravo PE, Pozios I, Pinheiro A, Merrill J, Tsui BM, Wahl RL, Bengel FM, Abraham MR, Abraham TP. Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy. Am J Cardiol. 2012 Oct 01; 110(7):1033-9. PMID: 22748357.
      View in: PubMed
    37. Vogel-Claussen J, Santaularia Tomas M, Newatia A, Boyce D, Pinheiro A, Abraham R, Abraham T, Bluemke DA. Cardiac MRI evaluation of hypertrophic cardiomyopathy: left ventricular outflow tract/aortic valve diameter ratio predicts severity of LVOT obstruction. J Magn Reson Imaging. 2012 Sep; 36(3):598-603. PMID: 22549972.
      View in: PubMed
    38. Bravo PE, Pinheiro A, Higuchi T, Rischpler C, Merrill J, Santaularia-Tomas M, Abraham MR, Wahl RL, Abraham TP, Bengel FM. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy. J Nucl Med. 2012 Mar; 53(3):407-14. PMID: 22315440.
      View in: PubMed
    39. Bonios M, Chang CY, Terrovitis J, Pinheiro A, Barth A, Dong P, Santaularia M, Foster DB, Raman V, Abraham TP, Abraham MR. Constitutive HIF-1a expression blunts the beneficial effects of cardiosphere-derived cell therapy in the heart by altering paracrine factor balance. J Cardiovasc Transl Res. 2011 Jun; 4(3):363-72. PMID: 21538185.
      View in: PubMed
    40. Wafae N, Ruiz CR, Abraham M, Freire CH, Demarchi GT, Wafae GC. Anatomy of the tendinous cords of the interventricular septum of the human heart. Ital J Anat Embryol. 2008 Oct-Dec; 113(4):273-9. PMID: 19507468.
      View in: PubMed
    41. Bonios MJ, Terrovitis JV, Abraham MR. Stem cell: "KANT" you see it? J Cardiovasc Transl Res. 2008 Jun; 1(2):103-5. PMID: 20559903.
      View in: PubMed
    42. Abraham MR, Olson LJ, Joyner MJ, Turner ST, Beck KC, Johnson BD. Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure. Circulation. 2002 Oct 01; 106(14):1794-9. PMID: 12356632.
      View in: PubMed